Pierre Fabre and Addex sign early-stage agreement in CNS field
8 September 2015 | By Victoria White
Addex Therapeutics has granted an option to license its metabotropic glutamate receptor subtype 3 (mGlu3 receptor) programme to Pierre Fabre...
List view / Grid view
News
ReViral announces $21m fundraising to advance RSV drug
8 September 2015 | By Victoria White
The funding will enable ReViral to progress its lead drug candidate, RV521, into proof of concept clinical trials and to continue the development of a novel series of antiviral inhibitors...
Kymab on Sunday Times Tech Track ‘Ones to Watch’ list
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
Immunocore ranks high in the Sunday Times Hiscox Tech Track 100
7 September 2015 | By Victoria White
Immunocore has been ranked as the Number one company in the southeast region of the UK and number nine overall in the Sunday Times Hiscox Tech Track 100...
Inhaled dosage form of BAL30072 to be formulated for patients with cystic fibrosis
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...
Wasp venom toxin MP1 blasts holes in cancer cells
4 September 2015 | By Victoria White
Research reveals exactly how the Polybia paulista wasp's venom toxin - called MP1 - selectively kills cancer cells without harming normal cells...
In conversation – Thoughts on the current status of the sequencing industry. An interview with Jacqueline Boultwood, University of Oxford
4 September 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford, a confirmed speaker at the congress, about her thoughts on the current status of the sequencing industry...
Final agenda is now available for our 2nd Annual Drug Discovery USA Congress in Boston
4 September 2015 | By Oxford Global
Production is now complete for the 2nd Annual Drug Discovery USA Congress taking place on the 29th & 30th of October 2015 in Boston, USA...
Aspirin could boost cancer immunotherapy
4 September 2015 | By Victoria White
Researchers have shown that combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice...
Another step closer to cheap synthetic antivenoms
4 September 2015 | By Victoria White
Researchers have successfully identified the exact composition of sea snake venom, which makes the future development of synthetic antivenoms more realistic...
Researchers use KG5 to sensitise tumours to radiation and chemotherapy
4 September 2015 | By Victoria White
Researchers have identified a pathway that causes resistance to chemotherapy and radiation treatments and a new drug, KG5, that targets this pathway...
Antisense RNAi therapeutics deals value approached $5.6 billion in 2014
3 September 2015 | By Victoria White
The deals market for antisense RNAi therapeutics witnessed a record year in 2014, with a total value of almost $5.6 billion across 59 transactions...
AmpliPhi appoints new VP of Chemisty, Manufacturing & Control
3 September 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that Alexander Gaidamaka has been appointed as the new Vice President of Chemistry, Manufacturing and Control...
Breakthrough in fighting liver disease
3 September 2015 | By Victoria White
The University of Brighton has announced it is sharing in a €5.9m EU grant to support the development of a new treatment for chronic liver disease...
Horizon and Redx sign cancer research collaboration
3 September 2015 | By Victoria White
Horizon and Redx have announced a new research collaboration to progress Redx’s pan-RAF inhibitor programme, for out-licensing in oncology indications...
